AMPLIFY ANSWERS Trademark

Trademark Overview


On Wednesday, November 19, 2014, a trademark application was filed for AMPLIFY ANSWERS with the United States Patent and Trademark Office. The USPTO has given the AMPLIFY ANSWERS trademark a serial number of 86459438. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 2, 2020. This trademark is owned by Adaptive Biotechnologies Corporation. The AMPLIFY ANSWERS trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Scientific and technological services and research and design relating thereto in the field of immune repertoire sequencing; providing clinical diagnostic assays and diagnostic or prognostic testing for detection of minimal residual disease in lymphoid malignancies; development of new technology for others in the field of biotechnology; DNA analysis services for scientific research purposes; genetic testing for scientific research purposes; laboratory research in the field of immune sequencing; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of immune sequencing; providing laboratory research services in the field of gene expression, namely, cancer biology; research and development in the biotechnology field

Medical services, namely, diagnostic services for the diagnosis and treatment of cancer, auto-immune conditions, and infectious diseases; medical services, namely, providing assays for tracking clones in an immune repertoire over time; medical services, namely, providing analysis, evaluation, and clinical reports of a patient's immune repertoire, including T cell or B cell clonal diversity and clone frequency; medical services, namely, providing diagnostic assays and diagnostic or prognostic testing for residual disease, and the analysis, evaluation, and reports of those test results to help healthcare professionals determine a patient's clinical diagnosis, prognosis or treatment, to assess the effectiveness of patient treatments, and to revise future treatments accordingly
amplify answers

General Information


Serial Number86459438
Word MarkAMPLIFY ANSWERS
Filing DateWednesday, November 19, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 2, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 5, 2018

Trademark Statements


Goods and ServicesScientific and technological services and research and design relating thereto in the field of immune repertoire sequencing; providing clinical diagnostic assays and diagnostic or prognostic testing for detection of minimal residual disease in lymphoid malignancies; development of new technology for others in the field of biotechnology; DNA analysis services for scientific research purposes; genetic testing for scientific research purposes; laboratory research in the field of immune sequencing; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of immune sequencing; providing laboratory research services in the field of gene expression, namely, cancer biology; research and development in the biotechnology field
Goods and ServicesMedical services, namely, diagnostic services for the diagnosis and treatment of cancer, auto-immune conditions, and infectious diseases; medical services, namely, providing assays for tracking clones in an immune repertoire over time; medical services, namely, providing analysis, evaluation, and clinical reports of a patient's immune repertoire, including T cell or B cell clonal diversity and clone frequency; medical services, namely, providing diagnostic assays and diagnostic or prognostic testing for residual disease, and the analysis, evaluation, and reports of those test results to help healthcare professionals determine a patient's clinical diagnosis, prognosis or treatment, to assess the effectiveness of patient treatments, and to revise future treatments accordingly

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, November 26, 2014
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 24, 2018
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAdaptive Biotechnologies Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98102

Party NameAdaptive Biotechnologies Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98102

Trademark Events


Event DateEvent Description
Monday, March 2, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 2, 2020ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 30, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 26, 2019EXTENSION 2 GRANTED
Friday, July 26, 2019EXTENSION 2 FILED
Friday, July 26, 2019TEAS EXTENSION RECEIVED
Saturday, January 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 17, 2019EXTENSION 1 GRANTED
Thursday, January 17, 2019EXTENSION 1 FILED
Thursday, January 17, 2019TEAS EXTENSION RECEIVED
Tuesday, July 31, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 5, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 5, 2018PUBLISHED FOR OPPOSITION
Wednesday, May 16, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 2, 2018LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 25, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 24, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 24, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 24, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 13, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 27, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, October 27, 2017NON-FINAL ACTION E-MAILED
Friday, October 27, 2017NON-FINAL ACTION WRITTEN
Thursday, October 26, 2017PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, October 24, 2017WITHDRAWN FROM PUB - OG REVIEW QUERY
Friday, October 6, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, October 3, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 3, 2017REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, October 3, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, October 3, 2016LETTER OF SUSPENSION E-MAILED
Monday, October 3, 2016SUSPENSION LETTER WRITTEN
Wednesday, September 21, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 21, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 21, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 21, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 21, 2016NON-FINAL ACTION E-MAILED
Monday, March 21, 2016NON-FINAL ACTION WRITTEN
Friday, March 18, 2016ASSIGNED TO LIE
Tuesday, September 15, 2015NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, September 15, 2015LETTER OF SUSPENSION E-MAILED
Tuesday, September 15, 2015SUSPENSION LETTER WRITTEN
Friday, September 11, 2015NOTICE OF REVIVAL - E-MAILED
Friday, September 11, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 11, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 11, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 11, 2015PETITION TO REVIVE-GRANTED
Friday, September 11, 2015TEAS PETITION TO REVIVE RECEIVED
Tuesday, March 10, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 10, 2015NON-FINAL ACTION E-MAILED
Tuesday, March 10, 2015NON-FINAL ACTION WRITTEN
Monday, March 9, 2015ASSIGNED TO EXAMINER
Wednesday, November 26, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, November 22, 2014NEW APPLICATION ENTERED IN TRAM